STVN:NYSE, Stevanato Group S.p.A.

Why STVN stock rose on November 13

Stevanato Group S.p.A. rose 10.0% on Friday, November 13, 2026, on 1,458,008 shares, 2.4 times its average daily volume. No headline about STVN came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

STVN stock overview

Stevanato Group S.p.A. (STVN:NYSE) closed at $15.80 on November 13, 2026, up 10.03% on the day. The stock trades 34.2% below its 52-week high of $24.01 and 31.1% above its 52-week low of $12.05. Over the past year, it lost 26.5%. Stevanato Group S.p.A. is part of the Health Care sector.

Key figures

Price
$15.80
Day change
+10.03%
Volume
1,458,008
Average volume
615,810
Market cap
4B+
52-week range
$12.05 – $24.01
50-day average
$19.25
200-day average
$17.92

Price action over the past year

In 252 trading sessions since November 13, 2025, STVN closed higher on 119 days (47%). Its best day was March 4, 2026 (+18.81%) and its worst was November 3, 2026 (-28.57%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

STVN news

About Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.

Similar stocks

Find more stocks like STVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.